Molecular Dynamics Simulation of DENV RNA-Dependent RNA-Polymerase with Potential Inhibitor of Disulfide Cyclic Peptide

Problem statement: Our researches have proposed two ligands of disulfide cyclic polypeptide, which are CDEEC and CDGSC as potential inhibitor of DENV RNA-dependent RNApolymerase by molecular docking. Approach: Methodological approach was conducted to determine the best ligand to act as inhibitor. Mo...

Full description

Saved in:
Bibliographic Details
Published inOnLine Journal of Biological Sciences Vol. 11; no. 2; pp. 48 - 62
Main Authors Tambunan, Usman Sumo Friend, Noors, Raima Syahidah, Parikesit, Arli Aditya, Ronggo, Elyana, Ronggo, Wahyu
Format Journal Article
LanguageEnglish
Published 30.09.2011
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Problem statement: Our researches have proposed two ligands of disulfide cyclic polypeptide, which are CDEEC and CDGSC as potential inhibitor of DENV RNA-dependent RNApolymerase by molecular docking. Approach: Methodological approach was conducted to determine the best ligand to act as inhibitor. Molecular docking simulation was conducted without a solvent in which enzyme was made rigid and ligand was leftfree to find the most suitable conformation. In actual cellular system there was a solvent which makes the enzyme to have a dynamic movement. Results: Molecular Dynamic (MD) simulation was performed to estimate more reliable condition of enzyme-ligand complex. Molecular dynamics simulation was performed during 5 ns with two different temperatures, 300 and 312 K. At the end of MD simulation at 300 K, CDEEC bound to two RdRp important residues, Arg-729 and Arg-737 while CDGSC didn't bind to any important residues. Conclusion: Simulation at 312 K also showed almost similar result. CDEEC is bound to two RdRP important residues, Arg-737 and Ser-710, whereas CDGSC don't bind to any important residues. Based on the result of these two simulations, CDEEC is proposed as a better inhibitor of RdRp dengue virus and feasible to be developed as anti-dengue drug.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1608-4217
1608-4217
DOI:10.3844/ojbsci.2011.48.62